Cyteir Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cyteir Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2023.
Cyteir Therapeutics, Inc. Assets for the quarter ending September 30, 2023 was $131M, a 19% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$131M	-$30.7M	-19%	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$134M	-$40M	-22.9%	Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$139M	-$47M	-25.3%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$153M	-$42.2M	-21.6%	Dec 31, 2022	10-Q	2023-11-06
Q3 2022	$162M	-$44.4M	-21.5%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$174M	-$27.7M	-13.7%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$186M			Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$195M	+$182M	+1323%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$206M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$202M			Jun 30, 2021	10-Q	2021-08-09
Q4 2020	$13.7M			Dec 31, 2020	10-K	2022-03-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.